Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBXN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
N4BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC12A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEGF8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM92 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFE2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM63A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR3C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5J2-PTCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DYNLT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on